Specialty Pharmacy

Ceritinib (Zykadia) could potentially be used as a first-line treatment in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer.

Prior research suggested that T cells become pathogenic when they encounter specific dendritic cells in the lymph nodes.

The recommended time to begin antiretroviral therapy has changed since it first arrived in the mid 90s for HIV.

Study cautions against unintended consequences of “shock and kill” treatment for HIV.

New findings may lead to therapeutic options for stopping lung cancer cells from spreading to different parts of the body.

Top news of the day from across the health care landscape.

Sofosbuvir/ribavirin treatment is typically prescribed for 12 weeks, but for some patients with hepatitis C virus, a longer duration may be needed.

Crisaborole ointment (Eucrisa) treats mild to moderate eczema in patients 2 years and older.

Ultraviolet light may improve research into multiple sclerosis immune response and allow for the treatment of inflammatory diseases that spares healthy tissue.

Increased presence of myocardial inflammation in patients with rheumatoid arthritis could be treated with non-TNFi biologic disease modifying anti-rheumatic drugs.

Treatment with Tecentriq helps successfully clear advanced lung cancer.

Celgene will continue trials with Abraxane plus immunotherapy drugs.

Alcohol could cause 7100 annual cancer deaths by 2035.

Blood test helps predict how aggressive lung cancer patients will respond to treatment.

Top news of the day from across the health care landscape.

Portal hypertension creates problems in patients coinfected with HIV and hepatitis C virus.

The combination drug Synjardy XR approved for use in patients with type 2 diabetes.

Switching from Glivec to Tasigna elicited a long-term response rate in patients with leukemia.

Lenalidomide (Revlimid) could potentially offer clinical benefits to patients with multiple myeloma.

Interim findings further support the efficacy, safety, and tolerability of Abraxane in NSCLC.

John Campo, vice president of Pharmacy Trade Relations and Contracting at Managed Health Care Associates discusses how to improve the relationship between specialty pharmacies and specialty drug manufacturers.

Some atopic dermatitis patients at risk for developing contact dermatitis from certain common ingredients in topical products.

Managing fatigue is a significant burden in multiple sclerosis.

Top news of the day from across the health care landscape.

Pioglitazone may increase a patient’s risk of developing bladder cancer.

The biggest spender doesn’t always come out ahead in the world of specialty medications.

Individuals with a history of cigarette smoking may benefit from regular ibuprofen use.

The proportion of specific inflammatory proteins can influence treatment outcomes.